Showing results (611-620 of 1,167) with videos related to

Sort By:
Pageof 117
Cell Research|November 29, 2025
Harnessing alternative splicing for off-the-shelf mRNA neoantigen vaccines in hepatocellular carcinomaHaichao Zhao, Yifei Cheng, Tiancheng Zhang, et al.
Clinical Proteomics|May 12, 2024
Mapping dynamic molecular changes in hippocampal subregions after traumatic brain injury through spatial proteomicsSudipa Maity, Yuanyu Huang, Mitchell D Kilgore, et al.
Molecular and Cellular Biochemistry|February 12, 2013
Down-regulation of DNA methyltransferase 3B in staurosporine-induced apoptosis and its mechanism in human hepatocarcinoma cell linesChao Zhao, Peng Yin, Chuanzhong Mei, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 30, 2002
Comparison between radioimmunotherapy and external beam radiation therapy for patients with hepatocellular carcinomaZhao-Chong Zeng, Zhao-You Tang, Bing-Hui Yang, et al.
Hepato-Gastroenterology|March 12, 2004
Radiation therapy for the locoregional lymph node metastases from hepatocellular carcinoma, phase I clinical trialZhao-Chong Zeng, Zhao-You Tang, Bing-Hui Yang, et al.
The Oncologist|April 26, 2017
Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative ResectionYi-Peng Fu, Yong Yi, Jin-Long Huang, et al.
Cell Death & Disease|May 12, 2018
microRNA-501-3p suppresses metastasis and progression of hepatocellular carcinoma through targeting LIN7AChubin Luo, Dan Yin, Hao Zhan, et al.
Cancer Research|November 18, 2008
Association of autophagy defect with a malignant phenotype and poor prognosis of hepatocellular carcinomaZhen-Bin Ding, Ying-Hong Shi, Jian Zhou, et al.
The Oncologist|November 11, 2008
Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resectionGuo-Huan Yang, Jia Fan, Yang Xu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Randomized, multicenter, open-label study of oxaliplatin plus fluorouracil/leucovorin versus doxorubicin as palliative chemotherapy in patients with advanced hepatocellular carcinoma from AsiaShukui Qin, Yuxian Bai, Ho Yeong Lim, et al.
Pageof 117